Journal profile · Pharmacology & Pharmacy
Drugs of today
ISSN 1699-3993 · eISSN 1699-4019 · Prous Science · SPAIN · Monthly · Founded 1998
Drugs of today: impact factor 3.93; subscription journal; review 6–12 weeks (community reports); community-reported acceptance: easy; 0 articles in 2025; indexed in Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
Drugs of today is published by Prous Science. By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical Economics and Policy, Diabetes Treatment and Management and Rheumatoid Arthritis Research and Therapies, together about 19.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
An international, peer-reviewed journal publishing monographs on new products entering the market and review articles. Since its inception in 1965, Drugs of Today has established a reputation for excellence in providing physicians and other key healthcare professionals with practical, up-to-date monographs on recently approved and launched drugs.
Source: LetPub
Research area (LetPub): Pharmacology & Pharmacy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance9.4%
- Diabetes Treatment and ManagementMedicine5.3%
- Rheumatoid Arthritis Research and TherapiesMedicine4.8%
- Pharmaceutical industry and healthcarePharmacology, Toxicology and Pharmaceutics4.8%
- Asthma and respiratory diseasesMedicine4.7%
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics4.4%
- Lung Cancer Treatments and MutationsMedicine4.2%
- Blood Pressure and Hypertension StudiesMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pharmacology (medical) | Q2 | 111/275 | 59th |
| Pharmacology | Q2 | 154/321 | 52nd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
Early warning / risk: Marked as ceased in SCIE on 21 November 2023. CAS Early Warning Journal List: not listed in any of 6 editions.LetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.93LetPub ·
- CiteScore 2026-06
- 4.6LetPub ·
- SJR 2026-06
- 0.49LetPub ·
- SNIP 2026-06
- 0.57LetPub ·
- h-index
- 46LetPub ·
- h-index
- 64OpenAlex ·
- i10-index
- 800OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 47LetPub ·
Articles by year OpenAlex count · 1,921 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 746 |
| 2025 | 0 | 0 | 1,258 |
| 2024 | 0 | 0 | 1,411 |
| 2023 | 18 | 2 | 1,446 |
| 2022 | 61 | 0 | 1,451 |
| 2021 | 64 | 1 | 1,510 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Prous Science
- Country or region
- SPAIN
- Language
- English
- Frequency
- Monthly
- Founded
- 1998
- ISSN
- 1699-3993
- Electronic ISSN
- 1699-4019
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Drugs of today
What is the impact factor of Drugs of today?
The latest impact factor listed by LetPub is 3.93; CiteScore 4.6, h-index 64.
How long does peer review take at Drugs of today?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Drugs of today?
According to LetPub and DOAJ records, Drugs of today is indexed in Scopus.
Is Drugs of today open access, and what is the APC?
Drugs of today is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .